Cargando…

Radiation and immune checkpoint inhibitors in the treatment of oligometastatic non-small-cell lung cancer: a practical review of rationale, recent data, and research questions

The combined use of stereotactic ablative radiotherapy (SABR) and immune checkpoint inhibitors (ICIs) is an emerging treatment paradigm for oligometastatic non-small-cell lung cancer (NSCLC). Recent phase I and II trial data suggest that SABR to multiple metastases in addition to ICI use is safe and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zayed, Sondos, Louie, Alexander V., Breadner, Daniel A., Palma, David A., Correa, Rohann J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Controversies in Immunotherapy for Patients with Lung Cancer: Pragmatic Solutions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331344/ https://www.ncbi.nlm.nih.gov/pubmed/37435562 http://dx.doi.org/10.1177/17588359231183668

Ejemplares similares

The role of thoracic consolidative radiotherapy in the setting of immunotherapy in extensive stage small cell lung cancer
por: Verma, Saurav, et al.
Publicado: (2023)

Efficacy of immunotherapy in oncogene-driven non-small-cell lung cancer
por: Vokes, Natalie I., et al.
Publicado: (2023)

Management of patients with brain metastases from NSCLC without a genetic driver alteration: upfront radiotherapy or immunotherapy?
por: Merkin, Ross D., et al.
Publicado: (2023)

Comparative efficacy and safety of novel immuno-chemotherapy for extensive-stage small-cell lung cancer: a network meta-analysis of randomized controlled trial
por: Zhu, Youwen, et al.
Publicado: (2023)

The prognostic value of TMB in early-stage non-small cell lung cancer: a systematic review and meta-analysis
por: Wankhede, Durgesh, et al.
Publicado: (2023)

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
por: Chen, Xuguang, et al.
Publicado: (2021)

Homogeneity effects in natural language semantics
por: Križ, Manuel
Publicado: (2019)

Clinicians’ Perceptions of a Modified Hospital Elder Life Program for Delirium Prevention during COVID-19
por: Schulman-Green, Dena J., et al.
Publicado: (2023)

Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors
por: Lu, Shun, et al.
Publicado: (2019)

Lung cancer screening: rationale and background
por: Diederich, S.
Publicado: (2011)

Immune checkpoint inhibitors in non-conventional histologies of renal-cell carcinoma
por: Bersanelli, Melissa, et al.
Publicado: (2023)

Technical Considerations in Stereotactic Ablative Radiotherapy for Localized Neuroendocrine Cancer of the Lung: Case Report and Review of the Literature
por: Callan, Laura, et al.
Publicado: (2018)

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience
por: Altan, Mehmet, et al.
Publicado: (2023)

Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Patients with Non-Small Cell Lung Cancer Resistant or Refractory to Immune Checkpoint Inhibitors
por: Barlesi, Fabrice, et al.
Publicado: (2022)

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)
por: Yamada, Tadaaki, et al.
Publicado: (2020)

Immune checkpoint inhibitors as first-line therapy for non-small cell lung cancer: A systematic evaluation and meta-analysis
por: Lu, Yu, et al.
Publicado: (2023)

Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients
por: Xie, Xiaohong, et al.
Publicado: (2023)

PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers
por: Lee, Elizabeth K., et al.
Publicado: (2020)

TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer
por: Li, Teng, et al.
Publicado: (2021)

Serum cytokine profiles and metabolic tumor burden in patients with non-small cell lung cancer undergoing palliative thoracic radiation therapy
por: Eide, Hanne A., et al.
Publicado: (2018)

A phase II study of atezolizumab for pretreated advanced/recurrent non-small cell lung cancer with idiopathic interstitial pneumonias: rationale and design for the TORG1936/AMBITIOUS study
por: Ikeda, Satoshi, et al.
Publicado: (2020)

Crossword Solutions
Publicado: (2019)

The Path from Survey Development to Knowledge Activism: A Case Study of the Use of a Physical Loads Survey in a Retail Workplace
por: Carlan, Nicolette, et al.
Publicado: (2022)

Strengthening Social Compact and Innovative Health Sector Collaborations in Addressing COVID-19 in South African Workplaces
por: Jeebhay, Mohamed F., et al.
Publicado: (2023)

Frontline Worker Safety in the Age of COVID-19: A Global Perspective
por: Kavanagh, Kevin T., et al.
Publicado: (2023)

Implications for high-precision dose radiation therapy planning or limited surgical resection after percutaneous computed tomography-guided lung nodule biopsy using a tract sealant
por: de Groot, Patricia M., et al.
Publicado: (2017)

Uptake of minimally invasive surgery and stereotactic body radiation therapy for early stage non-small cell lung cancer in the USA: an ecological study of secular trends using the National Cancer Database
por: Blom, Erik F, et al.
Publicado: (2020)

Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study
por: Zhou, Fei, et al.
Publicado: (2022)

Radical investment in the curriculum in times of Covid-19: Can we question the anti-science discourses?
por: Lopes, Alice Casimiro
Publicado: (2021)

Immune checkpoint inhibitors in ovarian cancer: where do we stand?
por: Leary, Alexandra, et al.
Publicado: (2021)

Four Key Questions Leaders Can Ask to Support Clinicians During the COVID-19 Pandemic Recovery Phase
por: Palamara, Kerri, et al.
Publicado: (2022)

A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer
por: Tinker, Anna V., et al.
Publicado: (2023)

Controversy: Is There a Role for Adjuvants in the Management of Male Pattern Hair Loss?
por: Rajput, Rajendrasingh J
Publicado: (2010)

Minimally Invasive Vitreoretinal Surgery: Is Sutureless Vitrectomy the Future of Vitreoretinal Surgery?
Publicado: (2011)

Botulinum Toxin Deaths: What is the Fact?
por: Omprakash HM,, et al.
Publicado: (2008)

Stability in Vitiligo: Why Such a Hullabaloo?
por: Gupta, Somesh
Publicado: (2009)

Stability in Vitiligo? What's that?
por: Lahiri, Koushik
Publicado: (2009)

Does Topical Tretinoin Used for Chemoprevention Cause Increased Mortality?
por: Sangolli, Prabhakar M
Publicado: (2009)

Radial Optic Neurotomy for Central Retinal Vein Occlusion
por: Ramezani, Ali-Reza
Publicado: (2009)

Resistance to apoptosis should not be taken as a hallmark of cancer
por: Wang, Rui-An, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7tg0j9c32p3tu8e0dlgjj5g37r